Carboplatin/cisplatin-etoposide is named as a drug or biological intervention in 2 clinical trials in our China and USA trial registers, none of which are currently recruiting. Lead sponsors include Shanghai Henlius Biotech (1) and Shandong Cancer Hospital and Institute (1). Registered phases: Phase 3 and Not applicable. Conditions studied include Limited-Stage Small Cell Lung Cancer; Solid Tumor Cancer; Chemotherapy Induced Neutropenia.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06649448 | A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. (ClinicalTrials.gov ↗) Solid Tumor Cancer, Chemotherapy Induced Neutropenia, G-CSF |
Not applicable | Not yet open |
| NCT05353257 | A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer (ClinicalTrials.gov ↗) Limited-Stage Small Cell Lung Cancer |
Phase 3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Limited-Stage Small Cell Lung Cancer | 1 |
| Solid Tumor Cancer | 1 |
| Chemotherapy Induced Neutropenia | 1 |
| G-CSF | 1 |
| Lead sponsor | Trials |
|---|---|
| Shanghai Henlius Biotech | 1 |
| Shandong Cancer Hospital and Institute | 1 |
| Register | Carboplatin/cisplatin-etoposide trials |
|---|---|
| Clinical trials in China | 2 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Carboplatin/cisplatin-etoposide works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Carboplatin/cisplatin-etoposide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.